Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16067 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Maeve E Wickham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Databases, Factual. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Aims
While diagnostic codes from administrative health data might be a valuable source to identify adverse drug events (ADEs), their ability to identify unintended harms remains unclear. We validated claims‐based diagnosis codes for ADEs based on events identified in a prospective cohort study and assessed whether key attributes predicted their documentation in administrative data.
Methods
This was a retrospective analysis of 3 prospective cohorts in British Columbia, from 2008 to 2015 ( n = 13 969). We linked prospectively identified ADEs to administrative insurance data to examine the sensitivity and specificity of different diagnostic code schemes. We used logistic regression to assess which key attributes (e.g., type of event, symptoms and culprit medications) were associated with better documentation of ADEs in administrative data.
Results
Among 1178 diagnosed events, the sensitivity of the diagnostic codes in administrative data ranged from 3.4 to 52.6%, depending on the database and codes used. We found that documentation was worse for certain types of ADEs (dose‐related: odds ratio [OR]: 0.32, 95% confidence interval [CI]: 0.15, 0.69; nonadherence events (OR: 0.35, 95% CI: 0.20, 0.62), and better for those experiencing arrhythmias (OR: 4.19, 95% CI: 0.96, 18.28).
Conclusion
ADEs were not well documented in administrative data. Alternative methods should be explored to capture ADEs for health research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of British Columbia, Vancouver, Canada.
- Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, Canada.
- Emergency Department, Vancouver General Hospital, Vancouver, Canada.
ORCID-Profile: Corinne M Hohl
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Wickham, M. E., McGrail, K. M., Law, M. R., Cragg, A., & Hohl, C. M. (2024). Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16067
Vancouver
Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16067
BibTeX
@article{Wickham2024,
author = {Wickham, Maeve E and McGrail, Kimberlyn M and Law, Michael R and Cragg, Amber and Hohl, Corinne M},
title = {Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16067}
}
EUVIMED